Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets

BACKGROUND: Mycobacterium tuberculosis continues to be a major pathogen in the third world, killing almost 2 million people a year by the most recent estimates. Even in industrialized countries, the emergence of multi-drug resistant (MDR) strains of tuberculosis hails the need to develop additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamshidi, Neema, Palsson, Bernhard Ø
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925256/
https://www.ncbi.nlm.nih.gov/pubmed/17555602
http://dx.doi.org/10.1186/1752-0509-1-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925256/
https://www.ncbi.nlm.nih.gov/pubmed/17555602
http://dx.doi.org/10.1186/1752-0509-1-26

Ejemplares similares